1. Bortezomib-based chemotherapy to treat refractory angioimmunoblastic T-cell lymphoma: A case report and review of the literature
   HUA-PING DU et al, 2016, Oncology Letters CrossRef
2. Bortezomib Use for a Critically Ill Patient with Angioimmunoblastic T-Cell Lymphoma
   Motoharu Shibusawa et al, 2022, Case Reports in Hematology CrossRef
3. Bortezomib, lenalidomide and dexamethasone (VRD) combination as salvage therapy in refractory angioimmunoblastic T cell lymphoma
   Driss Chaoui et al, 2014, British Journal of Haematology CrossRef